| X0405594 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs(5) | New Drug Application | 2004-09-30 | 深圳市海滨制药有限公司 | Shenzhen Haibin Pharmaceutical Co Ltd;Shanghai Institute of Pharmaceutical Industry | Certificate Issued | 2005-11-03 | view |
| X0403492 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs(5) | New Drug Application | 2004-06-30 | 珠海天翼医药技术开发有限公司 | Zhuhai Tianyi Pharmaceutical Technology Development Co Ltd | Certificate Issued | 2005-06-23 | view |
| JYHZ1700231 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | License Renew | 2018-01-19 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2018-03-28 | view |
| JYHZ1700230 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | License Renew | 2018-01-19 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2018-03-28 | view |
| JYHB2200082 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2022-02-15 | | Catalent Pharma Solutions LLC;Viatris Pharma Srl | | | view |
| JYHB2200081 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2022-02-15 | | Catalent Pharma Solutions LLC;Viatris Pharma Srl | | | view |
| JYHB2101341 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2021-08-19 | | Catalent Pharma Solutions LLC;Pfizer Established Medicine Italy Srl | | | view |
| JYHB2101340 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2021-08-19 | | Catalent Pharma Solutions LLC | | | view |
| JYHB2001374 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2020-08-21 | 辉瑞制药有限公司 | Viatris Pharmaceuticals (Dalian) Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Filed | 2020-09-02 | view |
| JYHB2001373 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2020-08-21 | 辉瑞制药有限公司 | Viatris Pharmaceuticals (Dalian) Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Filed | 2020-09-02 | view |
| JYHB2001321 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2020-08-21 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2020-12-30 | view |
| JYHB2001320 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2020-08-10 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2020-12-30 | view |
| JYHB1801286 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2018-11-12 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2018-12-05 | view |
| JYHB1801285 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2018-11-12 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2018-12-05 | view |
| JYHB1700683 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2017-05-13 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2017-07-18 | view |
| JYHB1700682 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2017-05-13 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2017-07-18 | view |
| JYHB1400901 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2014-07-04 | Pfizer Italia s.r.l | Pfizer Italia SRL;Catalent Pharma Solutions LLC | Certificate Issued | 2015-03-03 | view |
| JYHB1400900 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2014-07-04 | Pfizer Italia s.r.l | Pfizer Italia SRL;Catalent Pharma Solutions LLC | Certificate Issued | 2015-03-03 | view |
| JYHB1201252 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2012-11-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions Inc;Pfizer Italia SRL | Certificate Issued | 2013-06-13 | view |
| JYHB1201250 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2012-11-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions Inc;Pfizer Italia SRL | Certificate Issued | 2013-06-13 | view |
